[go: up one dir, main page]

HK1060067B - 含有et-743的抗肿瘤洽疗组合物 - Google Patents

含有et-743的抗肿瘤洽疗组合物 Download PDF

Info

Publication number
HK1060067B
HK1060067B HK04103120.3A HK04103120A HK1060067B HK 1060067 B HK1060067 B HK 1060067B HK 04103120 A HK04103120 A HK 04103120A HK 1060067 B HK1060067 B HK 1060067B
Authority
HK
Hong Kong
Prior art keywords
drug
use according
hour
exposure
combination
Prior art date
Application number
HK04103120.3A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1060067A1 (zh
Inventor
Naoto Takahashi
Steve Weitman
Maurizio D'incalci
Glynn Thomas Faicloth
Rafaella Giavazzi
Andreas Gescher
Original Assignee
Pharma Mar, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar, S.A. filed Critical Pharma Mar, S.A.
Priority claimed from PCT/GB2001/004902 external-priority patent/WO2002036135A2/en
Publication of HK1060067A1 publication Critical patent/HK1060067A1/zh
Publication of HK1060067B publication Critical patent/HK1060067B/zh

Links

HK04103120.3A 2000-11-06 2001-11-06 含有et-743的抗肿瘤洽疗组合物 HK1060067B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US24623300P 2000-11-06 2000-11-06
US60/246,233 2000-11-06
US24809500P 2000-11-13 2000-11-13
US60/248,095 2000-11-13
US34598201P 2001-10-19 2001-10-19
US60/345,982 2001-10-19
PCT/GB2001/004902 WO2002036135A2 (en) 2000-11-06 2001-11-06 Compositions for antitumour treatment containing ecteinascidin 743

Publications (2)

Publication Number Publication Date
HK1060067A1 HK1060067A1 (zh) 2004-07-30
HK1060067B true HK1060067B (zh) 2011-10-07

Family

ID=

Similar Documents

Publication Publication Date Title
EP1365808B1 (en) Compositions for antitumour treatment containing ecteinascidin 743
AU2002212499A1 (en) Compositions for antitumour treatment containing ecteinascidin 743
CA2373794C (en) Compositions and uses of et743 for treating cancer
CZ20013614A3 (cs) Terapeutický farmaceutický přípravek
RU2391101C2 (ru) Комбинированное применение эктеинасцидина-743 и содержащих платину противоопухолевых соединений
CN101123966A (zh) 包含使用et-743和多柔比星来治疗癌症的联合疗法
WO2009140675A2 (en) Combination therapy with an antitumor alkaloid
US20100009906A1 (en) Anticancer Treatments
JP2004535441A5 (zh)
CZ20021697A3 (cs) Farmaceutický přípravek obsahující aplidin pro léčení rakovinových onemocnění
HK1060067B (zh) 含有et-743的抗肿瘤洽疗组合物
RU2284818C2 (ru) Комбинированная химиотерапия
ES2358787T3 (es) Composiciones para tratamiento antitumoral que contienen ecteinascidina 743.
US20040110838A1 (en) Method of reducing toxicity of anticancer agents
EP1441717B1 (en) Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
Polyzos et al. Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel
NZ529801A (en) Compositions and uses of ET743 for treating cancer